MAR 22, 2018 05:00 AM PDT

Here Are the Two Genes Responsible for Nausea and Vomiting During Pregnancy

WRITTEN BY: Kara Marker

The second leading cause of hospitalization during pregnancy for expecting mothers is a severe form of normal morning sickness that is now linked to two genes. From the University of California - Los Angeles, researchers hope to develop new treatments for the condition, called hyperemesis gravidarum.

Something a little bit more than normal morning sickness during pregnancy involves severe nausea and vomiting affecting two percent of pregnant women. The cause of hyperemesis gravidarum was unknown before the present study, which identified two genes involved in the condition.

Hyperemesis gravidarum can cause significant and quick weight loss, malnutrition, and dehydration. In the worst cases, the condition can even result in a loss of pregnancy. Hyperemesis gravidarum is treated with dietary changes, rest, and antacids, but the most serious cases may require hospitalization for IV fluid and nutrition. Symptoms usually occur between four and six weeks of pregnancy and peak between nine and 13 weeks.

In their study, researchers compared variation in DNA from pregnant women with no nausea and vomiting to those with hyperemesis gravidarum. This led them to the identification of two genes, GDF15 and IGFBP7, which were then confirmed in an independent study of women, all participants of which had hyperemesis gravidarum.

Both GDF15 and IGFBP7 are involved in the development of the placenta, early pregnancy, and appetite regulation. In the past researchers instead believed pregnancy hormones like estrogen to be the cause of hyperemesis gravidarum.

The two genes are also linked to a metabolic disorder called cachexia that affects millions of people worldwide. Cachexia is a weight loss and muscle wasting condition that increases the risk of complications like infections, leading to death in 20 percent of cancer patients. Cachexia and hyperemesis gravidarum share many of the same symptoms.

Can genetic expression of GDF15 and IGFBP7 be altered to treat hyperemesis gravidarum? Researchers hope to answer this question going forward. "It is my hope that one day a medication that affects this pathway will be used to successfully treat and possibly cure hyperemesis gravidarum,” said first author Marlena Fejzo, who lost a pregnancy to this disease.

The present study was published in the journal Nature Communications.

Sources: American Pregnancy Association, Nature News & Comment, University of California - Los Angeles Health Sciences

About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
APR 16, 2018
Immunology
APR 16, 2018
Epstein-Barr Virus Raises Risk of 7 Diseases in Addition to Mono
The repercussions of an infection with Epstein-Barr virus (EBV) may not end with mononucleosis, “mono” or “the kissing disease.” Fi...
MAY 11, 2018
Cardiology
MAY 11, 2018
Gene Therapy to Reduce Risk of Cardiac Arrhythmia
During recovery from a heart attack, the danger is far from over. In a new study from scientists at the University of Bonn and an international team of col...
JUN 07, 2018
Genetics & Genomics
JUN 07, 2018
Easily Identifying Pregnancies at Risk for Premature Birth
Premature birth affects almost ten percent of pregnancies and is the leading cause of infant mortality in the US....
JUN 23, 2018
Clinical & Molecular DX
JUN 23, 2018
Algorithm-Based Blood Test Diagnoses Autism
As a developmental disorder, autism spectrum disorders (ASD) can be diagnosed as early as 18 to 24 months of age, but often the diagnosis does not come unt...
SEP 05, 2018
Clinical & Molecular DX
SEP 05, 2018
Iron-based MRI Contrast Outperforms Less Safe Method
A new method for loading iron inside nanoparticles creates MRI contrast agents that work better than the mainstay gadolinium chelates, which face increased...
SEP 24, 2018
Genetics & Genomics
SEP 24, 2018
Towards a Blood Test for Drowsy Driving
Driving is an everyday activity for many people around the world, and it comes with serious risks....
Loading Comments...